bioRxivBioinformaticsPreprint
ASOCompass: Context- and Chemistry-Aware Activity Prediction for Transferable Antisense Oligonucleotide Screening
Shuyu LiuiD, Jin ZhuoiD, Shuchang Lei, Tianhao WuiD, Jiaxuan HaniD, Chaoyi WuiD, Yanfeng Wang, Weidi Xie
Abstract
Antisense oligonucleotide (ASO) activity is jointly influenced by nucleotide sequence, chemical modification, target-RNA context, dose, delivery protocol, and cellular environment. Most existing computational screening methods model only a subset of these factors, limiting their ability to predict experimentally measured activity across heterogeneous screening conditions and previously unseen biological contexts. We introduce ASOCompass, a context-and chemistry-aware framework for ASO activity prediction and candidate ranking. ASOCompass integrates contextualized ASO and target-RNA sequence representations with position-specific molecular representations of chemical modifications. It further incorporates dose and delivery information together with prototype-adapted transcriptomic representations of target genes and cell lines. To encourage chemically and biophysically informative representations, the model is jointly trained on auxiliary molecular-property and sequence-derived thermodynamic prediction tasks. We evaluate ASOCompass on ASO Atlas, a large patent-derived dataset of RNase H-mediated gapmer ASOs, under held-out drug, target-gene, cell line, and joint gene-cell line settings. ASOCompass achieves an overall Spearman correlation of 0.5970, improving over the strongest ASO-specific baseline by 0.0421, and consistently performs best across all four distribution shifts. When adapted to unseen SOD1 and KLKB1 targets, ASOCompass also provides more accurate candidate ranking across different annotation budgets, reaching correlations of 0.830 and 0.696 with 1,024 target-specific labels. Additional analyses suggest that molecular-property supervision improves modification-specific ranking, while the auxiliary thermodynamic task produces representations more closely aligned with measured inhibition. These results demonstrate the potential of jointly modeling sequence, chemistry, and experimental-biological context for transferable ASO screening.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ASOFormer: a Transformer-based model for predicting antisense oligonucleotide efficacy to support therapeutic candidate prioritization
Nicholas C. Dove, Yuhao Min, … Xue Wang·bioRxiv·Sep 24, 2026
- Accurately modelling RNase H-mediated antisense oligonucleotide efficacy
Barney Hill, Maisie R. Jaques, … Carlo Rinaldi·Molecular Therapy — Nucleic AcidsPeer-reviewed·Jul 7, 2026
- Benchmarking Large Language Models for Predicting Therapeutic Antisense Oligonucleotide Efficacy
Abhinit Sundar, Zhi Stephen Wei, Griesmer·bioRxiv·Feb 19, 2026
- A CRISPR/Cas9 screen reveals proteins at the endosome-Golgi interface that modulate cellular ASO activity
Liza Malong, Jessica Roskosch, … Filip Roudnicky·Nature CommunicationsPeer-reviewed·Jun 30, 2025
- Mechanistic Insights into ASO-RNA Complexation: Advancing Antisense Oligonucleotide Design Strategies.
Johanna Hörberg, Antonio Carlesso, Anna Reymer·Molecular Therapy — Nucleic AcidsPeer-reviewed·Oct 4, 2024
- Syntheses of Pyrimidine-Modified Seleno-DNAs as Stable Antisense Molecules